166 related articles for article (PubMed ID: 25996140)
1. In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
Srivastava AK; Tewari M; Shukla HS; Roy BK
Arch Pharm (Weinheim); 2015 Aug; 348(8):548-55. PubMed ID: 25996140
[TBL] [Abstract][Full Text] [Related]
2. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population.
Iwanczak B; Laszewicz W; Iwanczak F; Dzierzanowska-Fangrat K; Rozynek M; Dzierzanowska D; Gosciniak G; Dlugosz J;
J Physiol Pharmacol; 2014 Dec; 65(6):801-7. PubMed ID: 25554984
[TBL] [Abstract][Full Text] [Related]
4. Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene A Protein Provide Insights into Suppression of Oncogenic Activities.
Srivastava AK; Singh D; Roy BK
Interdiscip Sci; 2017 Mar; 9(1):116-129. PubMed ID: 26798036
[TBL] [Abstract][Full Text] [Related]
5. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
[TBL] [Abstract][Full Text] [Related]
6. [The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Cheng H; Hu FL
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2754-7. PubMed ID: 16324315
[TBL] [Abstract][Full Text] [Related]
7. [First line therapy for Helicobacter pylori eradication in France].
Dupas JL
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
[TBL] [Abstract][Full Text] [Related]
8. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori primary resistant strains over 11 years in French children.
Kalach N; Serhal L; Asmar E; Campeotto F; Bergeret M; Dehecq E; Spyckerelle C; Charkaluk ML; Decoster A; Dupont C; Raymond J
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):217-22. PubMed ID: 17662555
[TBL] [Abstract][Full Text] [Related]
10. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J
J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811
[TBL] [Abstract][Full Text] [Related]
11. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
[TBL] [Abstract][Full Text] [Related]
12. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Nagahara A; Sato N
Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
[No Abstract] [Full Text] [Related]
13. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
Peretz A; Paritsky M; Nasser O; Brodsky D; Glyatman T; Segal S; On A
J Antibiot (Tokyo); 2014 Aug; 67(8):555-7. PubMed ID: 24781955
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
[TBL] [Abstract][Full Text] [Related]
15. [Drug sensitivity of Helicobacter pylori strains in children and young people from the region of Łódź].
Bak-Romaniszyn L; Planeta-Malecka I; Czkwianianc E; Rozynek E; Dzierzanowska D; Laszewicz W
Med Wieku Rozwoj; 2003; 7(2):129-35. PubMed ID: 12878783
[TBL] [Abstract][Full Text] [Related]
16. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
17. Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
Lee HJ; Kim JI; Cheung DY; Kim TH; Jun EJ; Oh JH; Chung WC; Kim BW; Kim SS; Park SH; Kim JK
J Infect Dis; 2013 Oct; 208(7):1123-30. PubMed ID: 23801607
[TBL] [Abstract][Full Text] [Related]
18. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
19. In vitro antagonism of rabeprazole and metronidazole upon clinical isolates of Helicobacter pylori.
Soto A; García A; González CL
Chemotherapy; 2009; 55(5):308-11. PubMed ID: 19556788
[TBL] [Abstract][Full Text] [Related]
20. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
Tabassum H; Ahmad IZ
Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
